Fellow
Columbia University Irving Medical Center
Dr. Michael Sang Hughes, MD, currently of the Columbia University Irving Medical Center, received his A.B. in Classics magna cum laude from Harvard College. He matriculated to Harvard Medical School, where he received his MD cum laude. He subsequently completed an Internal Medicine residency at the Johns Hopkins Bayview Medical Center. He is a current clinical fellow in Hematology-Oncology at the Columbia University Irving Medical Center, and he joined the Lentzsch Laboratory in 2023.
Dr. Hughes' prior research explored the interplay between cancers and the host immune system. As an undergraduate medical student, he worked with Dr. Kerry Reynolds and Michael Dougan to characterize immune checkpoint inhibitor-induced gastroenterocolitis. As a Johns Hopkins Physician Scientist Training Pathway scholar during his residency, Dr. Hughes worked with Dr. Ephraim Fuchs to investigate long-term outcomes of patients with peripheral T-cell lymphomas who undergo haploidentical blood and marrow transplantation.
Dr. Hughes' current research focuses on novel anti-AL amyloidosis fibril strategies as well as survival outcomes in multiple myeloma populations. He was selected for the 2024 American Society of Clinical Oncology Young Investigator Award.